Navigation Links
Biodefense Industry Response to New WMD Report Card
Date:1/26/2010

ANNAPOLIS, Md., Jan. 26 /PRNewswire-USNewswire/ -- The following is a statement by David Wright, President and CEO of PharmAthene, regarding the Commission on the Prevention of Weapons of Mass Destruction Proliferation and Terrorism Report Card:

Today's Report Card by the Commission on the Prevention of Weapons of Mass Destruction Proliferation and Terrorism sends a dire warning that America still remains vulnerable to bioterrorism.  Our Nation's ability to prevent and respond to a bioterrorist attack received an abysmal grade – 'F'. This is entirely unacceptable, especially when we have the solutions.  We have next generation medical countermeasures for anthrax that are languishing without adequate funding to ensure their procurement; we have leaders like Senators Graham and Talent, and many others, who are passionately dedicated to preventing WMD proliferation and terrorism.  As the Report Card makes clear, we need increased funding, more accountability, and less fragmented decision-making.   We have the answers and the solutions—it is imperative that we execute.  PharmAthene is committed to working with our partners in government to implement the solutions, and applauds Senators Graham and Talent for their leadership and dedication to this cause.

SOURCE PharmAthene


'/>"/>
SOURCE PharmAthene
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Isis Announces $4.2 Million in Government Contracts Awarded to Its Ibis Subsidiary for Biodefense Applications Development
2. Implicit Awarded US $16.3 Million U.S. Government Contract to Develop Immunomodulatory Drug for Biodefense Threats
3. HHS Secretary Leavitt Announces Members of the National Biodefense Science Board
4. Department of Health & Human Services Names Dr. Eric Rose to National Biodefense Science Board
5. Advanced Life Sciences to Present at Biodefense Session of 26th Annual JPMorgan Healthcare Conference
6. PharmAthene Signs Definitive Agreement to Acquire Biodefense Vaccines Business From Avecia
7. PharmAthene Closes Acquisition of Avecia Biodefense Vaccines Business Unit
8. Boston-Based BioDefense Corp. Announces New UK Partnership to Expand Markets for Biohazard Protection
9. Advanced Life Sciences Awarded U.S. Department of Defense Biodefense Contract Valued at up to $3.8 Million
10. PharmAthene and Panacea Biotec Ltd. Establish Strategic Alliance in Biodefense and Emerging Infectious Diseases
11. PharmAthene Signs Agreement with Medison Pharma Ltd. to Commercialize and Distribute Biodefense Medical Countermeasures in Israel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)...  In Atlanta, it seems everyone has a chance to ... create an expressive and dynamic community unlike any other. The ... to it. With their newest salon in ... to carry on that tradition with a unique, fresh approach ... salon is the newest of 13 nationwide locations, each of ...
(Date:2/23/2017)... ... 2017 , ... David Nolte, PhD accepted Purdue University’s 2016 ... Research Park of West Lafayette, Indiana. , The top commercialization award is ... success with, commercializing discoveries from Purdue research. “This award is truly an honor. ...
(Date:2/23/2017)... SAN FRANCISCO , Feb. 23, 2017   ... Beyond Type 1, a not-for-profit advocacy and education group ... a grant from Beyond Type 1 to support ViaCyte,s ... and other insulin-requiring diabetes.  For more ... cell-derived cell replacement therapies with a focus on the ...
(Date:2/22/2017)... SAN DIEGO , Feb. 22, 2017  PrimeVax ... , will be presenting at the Annual Biocom Global ... on March 2, at 11:15 AM, at the Torrey ... are thankful to the organizers at Biocom who have ... this international symposium of biotechnology companies, investors, and clinical ...
Breaking Biology Technology:
(Date:2/7/2017)... Feb. 7, 2017   MedNet Solutions , an ... spectrum of clinical research, is pleased to announce that ... its innovative, highly flexible and award winning eClinical solution, ... iMedNet is a proven Software-as-a-Service (SaaS) clinical ... Capture (EDC), but also delivers an entire suite of ...
(Date:2/3/2017)... Feb. 3, 2017  Texas Biomedical Research Institute announced that ... Larry Schlesinger as the Institute,s new President and CEO. ... May 31, 2017. He is currently the Chair of the ... Center for Microbial Interface Biology at Ohio State University. ... new President and CEO of Texas Biomed," said Dr. ...
(Date:2/2/2017)... TOKYO , Feb. 1, 2017  Central ... innovative and meaningful advances worldwide, The Japan Prize ... Japan Prize, who have pushed the envelope in ... Information and Communication. Three scientists are being recognized ... outstanding achievements that not only contribute to the ...
Breaking Biology News(10 mins):